Latest filing published 17 Mar 2023 for Adverum Biotechnologies, Inc., €5,318.
Filing timeline
BuySaleInsider track record
Brigit Riley: trading record in brief
Brigit Riley discloses dealings in Adverum Biotechnologies, Inc. to SEC (Form 4). Over a trading history stretching from 19 September 2022 to 15 March 2023, the count stands at 2 filings.
No open-market purchase appears, only 2 sales worth €13k. So far in 2023, the count stands at no purchases and 1 sale.
The newest entry dates from 17 March 2023: an open-market sale of €5,318, in Adverum Biotechnologies, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brigit Riley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,299 shares@ US$0.781640.7% of flowCommon StockSEC:0001209191-23-019841:0
- 7,266 shares@ US$1.069759.3% of flowCommon StockSEC:0001209191-22-050952:0
2 of 2 declarations